Certified by Founder Lodge
Debiopharm
Switzerland - Lausanne
INVESTOR
1 Disclosed Funding Rounds $16,428,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select lar
Iktos
Genialis
ViewsML
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Zócalo Health | $15,000,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
